Blue Water Acquisition IV, the fourth blank check company led by the founder of Blue Water Venture Partners targeting healthcare and tech, filed on Friday with the SEC to raise up to $125 million in an initial public offering. The company plans to raise $125 million by offering 12.5 million units at $10.00. Each unit consists of one share of common stock and one-half of one warrant, exercisable at $11.50. Blue Water Acquisition IV is led by CEO and Chairman Joseph Hernandez, the founder and Senior Managing Partner of investment firm Blue Water Venture Partners, and the founder of 2022 biotech IPO Blue Water Vaccines (now Onconetix; ONCO). The SPAC plans to target the biotechnology, healthcare, and technology sectors.
Read the full article: SPAC: Healthcare-Focused Blue Water Acquisition IV Files for a $125M IPO //
Source: https://www.renaissancecapital.com/IPO-Center/News/115385/SPAC-Healthcare-focused-Blue-Water-Acquisition-IV-files-for-a-$125-million-